Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Lucid Diagnostics Inc (LUCD)

Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,342
  • Shares Outstanding, K 59,342
  • Annual Sales, $ 2,430 K
  • Annual Income, $ -52,670 K
  • EBIT $ -44 M
  • EBITDA $ -42 M
  • 60-Month Beta 1.41
  • Price/Sales 23.36
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 1
  • High Estimate -0.18
  • Low Estimate -0.18
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +30.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8310 +19.75%
on 10/22/24
1.1200 -11.15%
on 11/13/24
+0.1552 (+18.48%)
since 10/21/24
3-Month
0.7300 +36.32%
on 09/23/24
1.1200 -11.15%
on 11/13/24
+0.1252 (+14.39%)
since 08/21/24
52-Week
0.6301 +57.93%
on 04/25/24
1.5800 -37.02%
on 01/19/24
-0.3049 (-23.45%)
since 11/21/23

Most Recent Stories

More News
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks

Penny stocks are a risky but potentially rewarding opportunity for investors willing to take on their uncertainty; these stocks may stand out from the pack.

KULR : 0.3898 (+0.59%)
ALUR : 0.4987 (+8.93%)
GEVO : 1.3500 (-2.17%)
LUCD : 1.0100 (+1.00%)
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference

/PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company operating in the medical device,...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
Lucid Diagnostics Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Precancer Detection

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
PAVmed Provides Business Update and Second Quarter Financial Results

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
Lucid Diagnostics Provides Business Update and Second Quarter Financial Results

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

LUCD : 1.0100 (+1.00%)
PAVM : 1.0620 (+3.11%)
PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023

/PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference

/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company and a...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device,...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)
PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

/PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the...

PAVM : 1.0620 (+3.11%)
LUCD : 1.0100 (+1.00%)

Business Summary

Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 1.1000
2nd Resistance Point 1.0600
1st Resistance Point 1.0300
Last Price 1.0100
1st Support Level 0.9600
2nd Support Level 0.9200
3rd Support Level 0.8900

See More

52-Week High 1.5800
Fibonacci 61.8% 1.2171
Fibonacci 50% 1.1051
Last Price 1.0100
Fibonacci 38.2% 0.9930
52-Week Low 0.6301

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar